Welcome to the Acumen Pharmaceuticals Q1 2025 conference call and webcast. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded.

Alexander Macrae; President, Chief Executive Officer, Director; Sangamo Therapeutics Inc Prathyusha Duraibabu; Chief Financial Officer, Senior Vice President; Sangamo Therapeutics Inc Good afternoon, ...

Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...

When L&D problems emerge, it’s natural to have a hunch about where the fault lies. But should you rely on that gut reaction?

Any budget-aware, environmentally conscious consumer scouting out new appliances knows to look for the Energy Star label. The ...

Record company Q1 revenue, increased 43.2% year over year to $116.5 millionGross margin increased from 21.2% to 36.9%, a 15.7 percentage point improvement year over year STAFFORD, Texas, May 12, 2025 ...

Submitted NDA for Anaphylm (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of An ...

WARSAW — Before they even get to kindergarten, Warsaw Community Schools is helping to educate local children. Monday, May 12, ...

PowerPoint’s built-in layouts are structured to support accessibility. They include tagged placeholders for titles and content that help screen readers understand the slide’s organization. Avoid using ...

No. 11 / 2025 Zealand Pharma Announces Financial Results for the First Three Months of 2025Significant progress in the clinical pipeline, strengthening of organizational capabilities, and strategic ...